Mary Spellman

Mary Spellman

Company: Clexio Biosciences

Job title: Medical Advisor

Seminars:

Introducing CLE-400; Topical Alpha-2- Adrenergic Agonist as a First-in- Class Treatment for Localized Chronic Pruritus 1:30 pm

Exploring activation of α2 adrenergic receptors on skin nociceptors in attenuating neural itch signaling Detailing the effects of CLE-400 in preclinical pharmacological models Presenting Notalgia Ptaresthetica as the first indication for CLE 400’s clinical developmentRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.